Ligand validation:7CJI

HTG: heptyl 1-thio-beta-D-glucopyranoside

HTG is a Ligand Of Interest in 7CJI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7CJI_HTG_B_624	77%	36%	0.105	0.943	1.06	1.45	2	5	0	0	100%	1
7CJI_HTG_b_624	66%	38%	0.124	0.93	1.05	1.38	2	2	0	0	100%	1
7CJI_HTG_C_522	17%	41%	0.288	0.869	0.91	1.36	1	1	0	0	100%	1
7CJI_HTG_b_621	13%	39%	0.238	0.782	0.99	1.38	1	2	0	0	100%	1
7CJI_HTG_c_522	10%	39%	0.31	0.821	0.99	1.39	2	1	0	0	100%	1
7CJI_HTG_B_621	10%	36%	0.259	0.758	0.97	1.55	1	4	0	0	100%	1
7CJI_HTG_h_101	9%	21%	0.299	0.813	1.14	2.13	2	7	0	0	84%	0.8421
7CJI_HTG_B_622	3%	41%	0.407	0.755	0.84	1.45	1	1	0	0	100%	1
7CJI_HTG_V_202	3%	65%	0.467	0.869	0.21	1.12	-	1	0	0	58%	0.5789
7CJI_HTG_D_413	2%	38%	0.329	0.64	1.11	1.33	2	1	0	0	84%	0.8421
7CJI_HTG_b_622	0%	32%	0.566	0.471	1	1.69	1	3	0	0	100%	1
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	40%	0.092	0.971	1.13	1.22	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	37%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	35%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	45%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.